Related Experiment Video
Updated: Jan 10, 2026

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
Published on: July 5, 2024
Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
Alexa C Dzienny1, David B Seifer1
1Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT 06510, USA.
Weight loss is crucial for managing obesity and polycystic ovarian syndrome (PCOS) in women. Interventions like diet, medication, and surgery improve reproductive health and reduce metabolic risks.
Area of Science:
- Reproductive Endocrinology
- Metabolic Health
- Obesity Medicine
Background:
- Obesity is a growing concern, affecting 41% of US women and increasing risks for adverse health events, including reproductive issues like menstrual irregularities and endometrial cancer.
- Obesity is closely linked with polycystic ovarian syndrome (PCOS), characterized by hyperandrogenism and anovulation. Women with both conditions often experience a more severe phenotype, with heightened risks for chronic anovulation, metabolic disturbances, and reduced fertility.
- Weight management is fundamental for patients with obesity and PCOS, improving cardiovascular risk factors, menstrual regularity, ovulation, and pregnancy rates.
Purpose of the Study:
- To review and compare various weight loss strategies for women with obesity and PCOS.
- To provide clinicians with evidence-based information to guide individualized treatment decisions for PCOS management.
- To explore the impact of lifestyle modifications, medications, and bariatric surgery on PCOS symptoms and associated health risks.
Main Methods:
- This narrative review synthesizes current literature on weight loss interventions for women with obesity and PCOS.
- It compares the efficacy of lifestyle modifications (diet, exercise, behavioral therapies), pharmacotherapy (e.g., GLP-1 receptor agonists), and bariatric surgery.
- The review considers factors such as patient goals, risk tolerance, and comorbidities in treatment selection.
Main Results:
- Lifestyle modifications, including low glycemic index diets (ketogenic, DASH) and vitamin D supplementation, are foundational first-line interventions.
- Emerging data highlight the role of newer weight loss medications, such as GLP-1 receptor agonists, in managing PCOS and cardiovascular risk.
- Bariatric surgery and pharmacotherapy offer significant weight loss and metabolic improvements, though require personalized assessment of risks and benefits.
Conclusions:
- A personalized approach is essential for treating PCOS in women with obesity, considering individual reproductive aspirations and health status.
- Weight loss interventions significantly improve hormonal balance, insulin sensitivity, menstrual function, and fertility in women with PCOS and obesity.
- Clinicians should carefully evaluate patient-specific factors to recommend the most effective and sustainable weight loss strategy for managing PCOS.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Obesity
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Atherosclerosis III: Management

